Diabetes comes at a high cost for society. The treatment is very costly, primarily due to the prevalence and increased incidence of the disease. Amputations are especially demanding due to long treatments, rehabilitation, increased care and home care needs, as well as due to productions losses, as these persons will often live on a disability pension.
In 1998, the cost for diabetic ulcer treatment in Sweden was estimated averaged € 7,000 per patient, and the cost for shank amputations at approx. € 53,000 per patient1 .
In the United States, the American Diabetes Association in 2012 estimated the total financial diabetes costs at € 230 billion—€ 165 billion of which was for direct medical costs. This amounts to a 41% increase in five years as the 2007 estimate was € 165 billion.2.
For 2007, the cost of diabetes related ulcers in the United States was estimated at just[UR3] over € 26 billion. [JP4] In the United Kingdom, the corresponding cost amounted to approx. € 50 billion, and in Sweden in 1998, approx. € 0.2 billion3
1, http://www.internetmedicin.se, diabetesfoten (”the diabetic foot”)
3, The cost of diabetic foot: The economic case for the limb salvage team; Journal of vascular suregy 2010;52:17S, Vickie R. Driver